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Abstract: The diagnostic speciﬁ  city of poor premorbid intelligence is controversial. We explored 
premorbid intelligence level in psychiatric patients with personality disorders, depressive 
disorders, bipolar disorders and schizophrenic disorders. 273 consecutively admitted patients 
and 81 controls were included in the study and tested with the ‘Test di Intelligenza Breve’, an 
Italian adaptation of the National Adult Reading Test. Signiﬁ  cant differences between the clinical 
samples and the control subjects were found but not among the 4 clinical groups. The observation 
of premorbid IQ deﬁ  cits in subjects with diagnoses other than schizophrenia suggests a common 
vulnerability diathesis, which is most likely to have a neurodevelopmental basis.
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Introduction
Although poor premorbid intelligence among subjects with schizophrenia is a consistent 
ﬁ  nding (Woodberry et al 2008), there are still some controversies about its diagnostic 
speciﬁ  city. There are few data on premorbid cognitive functioning in subjects with 
diagnoses other than schizophrenia, reporting conﬂ  icting results. Cannon et al (1997) 
reported subjects with schizophrenia more impaired on premorbid IQ scores than 
those suffering from affective disorders. In a prospective study, van Os et al (1997) 
demonstrated that subjects with chronic affective illnesses were more cognitively 
impaired during childhood and adolescence than controls. Others studies have shown no 
or few differences between subjects with schizophrenia and non-psychotic psychiatric 
disorders (Isohanni et al 1998).
More recently Mortensen et al (2005) reported that schizophrenia and related 
disorders, other psychotic disorders, adjustment, personality, alcohol and substance use 
related disorders but not mood disorders as well as neuroses and related disorders were 
signiﬁ  cantly associated with low IQ scores. On the other hand, results of Tiihonen et al 
(2005) indicate that premorbid intellectual ability, in terms of visuospatial reasoning, 
is impaired in bipolar disorder and schizophrenia and, to a smaller extent, in other 
psychoses suggesting a possible shared aetiology.
Several studies ﬁ  nally report that the association between cognitive deﬁ  cits and 
functional impairment may exist across most diagnostic entities (Zammit et al 2004; 
Weiser et al 2004).
There is therefore a rationale for further studies examining whether low IQ test 
scores are speciﬁ  cally associated with schizophrenia or are a marker of increased 
vulnerability to the development of a broader range of psychiatric disorders.
In the present study we aimed to investigate the premorbid intelligence level 
across diagnoses in psychiatric patients during an index admission. Lacking IQ 
evaluations before the illness onset, we used the ‘Test di Intelligenza Breve’ (TIB), 
Italian adaptation of the National Adult Reading Test (NART) (Sartori et al 
1997; Nelson 1982). This instrument is based on reading task, considered a valid Neuropsychiatric Disease and Treatment 2008:4(6) 1242
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and clinically useful method to investigate premorbid 
intellectual abilities (Crawford et al 1990; Grifﬁ  n et al 2002; 
Stratta et al 2007).
Method
Clinical sample
Consecutively admitted patients to Villa Serena Medical 
Centre, Psychiatry Unit, Città S. Angelo (Italy) were included 
if they fulﬁ  lled the following criteria: 1) informed consent 
to participate in the study; 2) less than 55 years of age; and 
3) no history of organic brain disease, 4) mood, personality 
and schizophrenic disorders. Subjects were diagnosed 
according to DSM-IV criteria and all available clinical and 
historical information collected during the hospital stay, 
by two senior psychiatrists (AR and PS), who personally 
interviewed the patients.
The local Ethics Committee approved the study 
procedures. All subjects entering the protocol provided 
informed consent after receiving a complete description of 
the study.
A total of 273 subjects were enrolled in the study: 
79 (28.94%) women and 194 men, with a mean age of 
43.31 years (SD 13.97). Educational level was 9.92 (SD 3.84). 
DSM-IV diagnoses were personality disorder (N = 56), 
depressive disorder (N = 51), bipolar disorder (N = 64), 
schizophrenic disorder (N = 102).
Because of high cluster A, B and C comorbidity, 
we decided to group personality disorders together. No other 
diagnoses were a priori considered for IQ evaluation in so 
far as only marginally represented among inpatient sample. 
The referral centre does not admit dual diagnoses.
Control subjects
Control subjects were recruited from the local community 
[81 subjects, 50 women and 31 men; mean age 40.42 
(SD 9.26), educational level 12.51 (SD 3.32)].
Because the patient group may have had a decline in 
cognitive function, an effort was made to match patient and 
control groups as closely as possible on age and socioeconomic 
status. Thus, the control data provide an estimate of the 
cognitive function level expected in individuals with the same 
socioeconomic background of the patient group.
Procedure
Subjects were tested using the ‘Test di Intelligenza 
Breve’ (TIB) (Sartori et al 1997) just before discharge, in a 
remission phase. The TIB consists of 54 words (34 effective 
test-words with irregular accent and 20 control-words with high 
frequency of use), that subjects have to read and pronounce. 
The total number of mistakes of reading deﬁ  nes the TIB 
error score. The estimated IQ scores (ie, performance, verbal 
and total) are calculated through the regression of equations 
taking into account sex, age and educational level: estimated 
performance IQ = (0.194 × age) + (–1.154 × TIB errors) + 
107.364; estimated verbal IQ = (4.198 × sex F = 0 M = 1) + 
(0.938 × educational level) + (–0.893 × TIB errors) + 99.536; 
estimated total IQ = (0.659 × educational level) + 
(–0.947 × TIB errors) + 107.58.
The Clinical Global Impression-Severity (CGI-S) 
(Guy 1976) and the Global Assessment of Functioning (GAF) 
Scale (DSM IV, Axis V, APA 1995) for the assessment of 
the psychological, social, and occupational functioning were 
obtained for patient groups.
Results
Sex distribution was different, but no between sex 
comparisons reached signiﬁ  cance. No differences in age and 
educational level were seen among the four clinical groups. 
No differences for age between clinical sample and healthy 
subjects were seen. However controls were more educated 
(Table 1).
The data of the clinical as well as the control samples were 
appreciably normally distributed (Kolmogorov-Smirnov tests 
from 0.65 to 1.18, all not signiﬁ  cant). One way ANOVAs 
on estimated IQs showed signiﬁ  cant differences between the 
clinical samples and the control subjects (Scheffé tests all 
signiﬁ  cant at 0.0005 level), without any difference between 
them (Table 1).
Correlations among educational level and estimated IQs 
have been performed: educational level vs Total IQ r = 0.83, 
vs Performance IQ r = 0.65; vs Verbal IQ r = 0.84, all 
p  0.0005. Although educational level was included in the 
estimated IQs calculation, we tentatively considered this 
variable as covariate. No differences were seen among the 
clinical samples and IQs remained signiﬁ  cantly different 
between patients and controls (Table 1).
CGI and GAF evaluations were performed to get 
more information on the clinical variability: subjects with 
schizophrenia only differed from the other samples with more 
severe disorder and impaired functioning (Table 1).
Discussion
The lack of premorbid IQ level speciﬁ  city among different 
diagnoses, such as schizophrenia, affective and personality 
disorders conﬁ  rms results of recent studies (Zammit et al 
2004; Weiser et al 2004; Mortensen et al 2005).Neuropsychiatric Disease and Treatment 2008:4(6 ) 1243
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These data suggest a vulnerability diathesis likely having 
a neurodevelopmental origin such as sub optimal brain 
development. This vulnerability diathesis can lead to a mental 
disorder due to attentional difﬁ  culties, distorted perceptions 
and cognitive interpretation of stimuli which is precipitated 
possibly by distressing events leading to unusual thought 
processes, decreased empathic ability and social functioning 
(Mueser and McGurk 2004).
Even though we are aware that other factors could have 
inﬂ  uenced IQ performance (ie, medication, time of testing), 
we attempted to consider the role of general factors affecting 
clinical outcome using CGI-S and GAF. Subjects with 
schizophrenia did have a more severe disorder but similar to 
other groups premorbid IQ. Different genetic and environmen-
tal factors interacting with premorbid IQ can orient towards 
different phenotypical outcomes (ie, diagnoses, severity of 
illness, global functioning) (Gottesman and Gould 2003).
However, premorbid IQ is associated with poorer 
outcome and higher mortality (Munro et al 2002; Batty et al 
2007) and it has also been shown to have a pathoplastic effect 
on symptom presentation in functional psychoses (Stratta 
et al 2007), ie, inﬂ  uencing the symptom expression during an 
index episode. The premorbid IQ, among other factors, could 
therefore affect this ‘intermediate outcome’ and, having an 
effect on symptomatology, obscure diagnostic boundary.
The lack of inclusion of patients with other diagnoses 
limits the conclusions of this study to the sample described. 
The role of premorbid IQ in outpatients with other diagnoses 
deserves further investigation.
Although not surprising and not the primary aim of the 
study, the observation of a difference between controls and 
patients deserves some comments.
Several reasons could lead to overestimate a between 
group difference. The choice of a not adequate control sample 
could be the ﬁ  rst. Although we selected a control group of 
similar age, socioeconomic status and environment, the 
educational level was different.
The relevance of educational level to neurocognitive 
measures has been widely discussed in the literature (Stratta 
et al 2001). It is conceivable that the illness onset could 
limit further achievement, thus contaminating the measure 
of educational level. Equating patients and controls on a 
variable (ie, educational level) that is descriptive of the 
disease outcome process may lead to a ‘matching fallacy’ 
(Meheel 1970), with the risk of biased comparisons, 
contrasting overachieving patients with underachieving 
controls (Rossi et al 1991).
However, when educational level was controlled by 
covariance, results were similar and, above all, no differences 
among patients emerged. Moreover the data we reported are 
in line with those of premorbid IQ estimated in similar control 
samples obtained by different tools: TIB (Sartori et al 1997), 
NART (eg, Kerr et al 2003), WAIS-R (eg, O’Leary et al 
2000). It could be possible that recruiting admitted patients 
produces a bias with less severe patients and putatively less 
impaired IQ excluded: if subjects with low IQ are more 
likely than subjects with high IQ to be admitted to hospital, 
an overestimation of an association between low IQ and 
Table 1 Socio-demographic, clinical characteristics and estimated IQs in the clinical samples and in control subjects [mean (SD)]
N Age Educational 
level
CGI-S GAF Total IQ Verbal IQ Perfor-mance 
IQ
Personality disorders 56 40.81 (10.38) 8.91 (3.51) 3.9 (1.2) 66.0 (12.0) 100.14 (9.64) 98.79 (10.36) 99.06 (9.39)
Depressive disorder 51 46.77 (14.42) 8.33 (4.06) 3.5 (0.9) 70.0 (9.1) 100.11 (11.61) 97.68 (12.86) 100.64 (9.95)
Bipolar disorder 64 43.88 (12.52) 9.60 (3.93) 3.7 (1.0) 65.9 (10.5) 101.76 (10.61) 99.58 (11.51) 101.07 (10.48)
Schizophrenic disorder 102 42.60 (15.99) 9.79 (3.77) 4.5 (1.2) 55.8 (12.5) 102.12 (10.32) 100.74 (10.80) 101.11 (10.17)
Control subjects 81 40.42 (9.26) 12.51 (3.32) 111.20 (5.40) 109.58 (6.78) 109.44 (4.56)
One way ANOVA F = 2.30 
NS
F = 13.25 
p  0.0005§
F = 12.18 
p  0.0005*
F = 22.75 
p  0.0005*
F = 17.45 
p  0.0005§
F = 15.41 
p  0.0005§
F = 15.41 
p  0.0005§
One way ANCOVA+ F = 5.03 
p  0.001
F = 3.09 
p  0.025
F = 5.26 
p  0.005
Regression analysis for 
covariates
Educational level t = 25.72 
p  0.0005
t = 26.78 
p  0.0005
t = 14.27 
p  0.0005
Scheffé tests.
*Subjects with schizophrenia vs the other clinical groups differ at a 0.05 level (d.f. 3.272).
§Clinical samples vs control subjects: all signiﬁ  cant at a 0.0005 level (d.f. 4,353).
+Educational level as covariate (d.f. 4,353).Neuropsychiatric Disease and Treatment 2008:4(6) 1244
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disorder could occur. However Zammit et al (2004) did 
not ﬁ  nd association between IQ and illness severity but 
we reported that premorbid IQ could inﬂ  uence symptoms 
presentation (Stratta et al 2007).
On the other hand the differences between patients and 
controls could be underestimated: tests of reading ability 
(eg, NART) provide an accurate estimate of premorbid IQ 
for individuals in the average range of intelligence, while 
it appears of relatively lower utility for individuals at the 
lower end of IQ range due to the overestimation of their 
performance (Grifﬁ  n et al 2002).
Preventive intervention on more susceptible people could 
be an important aim, and evaluation of cognitive abilities in 
adolescence or early adulthood a useful tool to identify at 
risk individuals (Verdoux and Liraud 2000).
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